|
Rudy Dekeyser
Rudy Dekeyser was until May 2012 the Managing Director of VIB (the Flanders Institute for Biotechnology). He was until May 2012 head of the technology transfer team of the institute. He obtained a PhD in molecular biology at the University of Ghent. He was director of DevGen and CropDesign and is a director of the biotech companies Ablynx, Peakadilly, Actogenix, EMBLEM (technology transfer company of EMBL) and FlandersBio. He is also co-founder of ASTP (Association or European Science and Technology Professionals) and visiting professor ''innovation and management'' at the University of Ghent Ghent University ( nl, Universiteit Gent, abbreviated as UGent) is a public research university located in Ghent, Belgium. Established before the state of Belgium itself, the university was founded by the Dutch King William I in 1817, when the .... References * Caplan A, Dekeyser R, Van Montagu M, Selectable markers for rice transformation, Methods Enzymol. 1992;216:426–41. * Claes ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Vlaams Instituut Voor Biotechnologie
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe. The institute is led by Christine Durinx and Jérôme Van Biervliet. Ajit Shetty is chairman of the board of directors. Goals VIB's mission is ''to conduct frontline biomolecular research in life sciences for the benefit of scientific progress and the benefit of society''. The strategic goals of the VIB are: # Strategic basic research # Technology transfer po ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Molecular Biology
Molecular biology is the branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions. The study of chemical and physical structure of biological macromolecules is known as molecular biology. Molecular biology was first described as an approach focused on the underpinnings of biological phenomena - uncovering the structures of biological molecules as well as their interactions, and how these interactions explain observations of classical biology. In 1945 the term molecular biology was used by physicist William Astbury. In 1953 Francis Crick, James Watson, Rosalind Franklin, and colleagues, working at Medical Research Council unit, Cavendish laboratory, Cambridge (now the MRC Laboratory of Molecular Biology), made a double helix model of DNA which changed the entire research scenario. They proposed the DNA structure based on previous research done by Ro ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
University Of Ghent
Ghent University ( nl, Universiteit Gent, abbreviated as UGent) is a public research university located in Ghent, Belgium. Established before the state of Belgium itself, the university was founded by the Dutch King William I in 1817, when the region was incorporated into the United Kingdom of the Netherlands after the fall of First French Empire. In that same year, he founded two other universities for the southern provinces as well, alongside Ghent University: University of Liège and State University of Leuven. After the Belgian revolution of 1830, the newly formed Belgian state began to administer Ghent University. In 1930, UGent became the first Dutch-speaking university in Belgium. Previously, French (and, even earlier, Latin) had been the standard academic language in what was ''Université de Gand''. In 1991, it was granted major autonomy and changed its name accordingly from ''State University of Ghent'' ( nl, Rijksuniversiteit Gent, abbreviated as ''RUG'') to its c ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
DevGen
Devgen is a Belgium-based multinational agricultural biotechnology company. It uses biotechnology and molecular breeding technologies to develop varieties of food crops. Its technology is marketed by outlicensing or selling seeds in India and South-East Asia. Devgen also develops nematicides. History RNA interference spin off Devgen was founded as a spin-off of Ghent University and The Flemish Institute for Biotechnology in 1997 to commercialize intellectual property it licensed on the use of RNAi in nematodes and its use for screening for therapeutics and/or their targets. Its work focused on the nematode ''C. elegans'' as a model system, which functions as a model for human diseases, but also as a model for the kind of nematodes that are agricultural pests. The company raised 37 million Euro in its first three years, first from the GIMV and Abingworth investment companies at its launch, then from the IWT, then from another round of private investors including ING, KBC, L ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
CropDesign
CropDesign is a biotech company located in Ghent, Belgium. The company develops a portfolio of agronomic traits for the global commercial seed markets. It has developed a technology platform to discover genetic traits for the improvement of corn, rice and other plants. Current Managing Director is Juergen Logemann. History CropDesign was founded in 1998 as a spin-off from the Flanders Institute of Biotechnology (VIB) and the Institute of Plant Biotechnology for Developing Countries of the University of Ghent. One of the founders of the company is Marc Van Montagu who is a Flemish pioneer in plant genetics. Another co-founder was Professor Dirk Inzé, specialist in plant cell cycle technologies. The company was financially backed until 2006 by a consortium of venture capital funds led by the GIMV. BASF Plant Science acquired the company in 2006. The company announced in May 2016 that they would cease operations by the end of the year. BASF stated at the time that they wished ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ablynx
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent. History In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of was provided by Gimv. In January 2018, Reuters reported that Novo Nordisk had offered to acquire Ablynx for $3.1 billion — having made an unreported offer in mid-December for the company. However, the Ablynx board rejected this offer the same day, saying that the price undervalued the business. In January 2018, they were acquired by Sanofi Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Syn ... for $4.8 Billion. The acquisition was led by Chief Broker Gle ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Actogenix
''Lactococcus lactis'' is a Gram-positive bacterium used extensively in the production of buttermilk and cheese, but has also become famous as the first genetically modified organism to be used alive for the treatment of human disease. ''L. lactis'' cells are cocci that group in pairs and short chains, and, depending on growth conditions, appear ovoid with a typical length of 0.5 - 1.5 µm. ''L. lactis'' does not produce spores ( nonsporulating) and are not motile ( nonmotile). They have a homofermentative metabolism, meaning they produce lactic acid from sugars. They've also been reported to produce exclusive L-(+)-lactic acid. However, reported D-(−)-lactic acid can be produced when cultured at low pH. The capability to produce lactic acid is one of the reasons why ''L. lactis'' is one of the most important microorganisms in the dairy industry. Based on its history in food fermentation, ''L. lactis'' has generally recognized as safe (GRAS) status, with few case reports ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
EMBL
The European Molecular Biology Laboratory (EMBL) is an intergovernmental organization dedicated to molecular biology research and is supported by 27 member states, two prospect states, and one associate member state. EMBL was created in 1974 and is funded by public research money from its member states. Research at EMBL is conducted by approximately 110 independent research and service groups and teams covering the spectrum of molecular biology and bioinformatics. The list of Groups and Teams at EMBL can be found at . The Laboratory operates from six sites: the main laboratory in Heidelberg, and sites in Hinxton (the European Bioinformatics Institute (EBI), in England), Grenoble (France), Hamburg (Germany), Rome (Italy) and Barcelona (Spain). EMBL groups and laboratories perform basic research in molecular biology and molecular medicine as well as train scientists, students, and visitors. The organization aids in the development of services, new instruments and methods, and techno ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
FlandersBio
flanders.bio, founded in 2004, is the networking organisation for the life sciences sector in Flanders and represents and supports around 350 member companies. The key strategic objectives of flanders.bio are knowledge exchange and valorisation, human capital development, internationalization of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of flanders.bio. The flanders.bio network brings together companies with activities in the life sciences – companies that are for example developing biopharmaceuticals, medical technologies or agricultural or industrial biotech products. The network also welcomes research institutes, universities and providers of capital, services and technologies to the life sciences community. Since 2018, Willem Dhooge and Pascale Engelen are both co-General Managers at flanders.bio. They were preceded by Henk Joos, Ann De Beu ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
